Share Price and Basic Stock Data
Last Updated: November 10, 2025, 8:58 pm
| PEG Ratio | -0.68 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Gujarat Narmada Valley Fertilizers & Chemicals Ltd operates in the fertilisers sector, reporting a market capitalization of ₹7,484 Cr. The company’s sales have shown notable fluctuations over recent quarters, with a peak of ₹2,696 Cr in June 2022 and a decline to ₹1,652 Cr by June 2023. However, sales recovered to ₹2,080 Cr in September 2023, indicating a possible turnaround. For the fiscal year ending March 2023, total sales stood at ₹10,227 Cr, a significant increase from ₹8,642 Cr in the previous year. This growth trajectory is complemented by a trailing twelve months (TTM) sales figure of ₹7,472 Cr, suggesting a potential for recovery despite the recent quarterly volatility. The company’s operational performance, reflected in its sales figures, positions it as a key player within the Indian fertilisers market, which is characterized by cyclical demand patterns influenced by agricultural seasons and commodity prices.
Profitability and Efficiency Metrics
The profitability metrics for Gujarat Narmada Valley Fertilizers & Chemicals reveal both strengths and weaknesses. The company reported a net profit of ₹548 Cr, translating to a net profit margin of 7.41% for the financial year ending March 2025. Operating Profit Margin (OPM) stood at 14.14% for the same period, indicating a decline from previous highs, reflecting challenges in cost management. The Interest Coverage Ratio (ICR) was an impressive 48.63x, highlighting the company’s capacity to meet its interest obligations, suggesting a solid financial footing despite lower profitability margins. Furthermore, the Return on Capital Employed (ROCE) recorded at 8.25% and Return on Equity (ROE) at 6.97% are modest compared to industry benchmarks, suggesting that the company may need to enhance operational efficiency to improve returns. The efficiency metrics indicate that while the company maintains a strong ability to cover its financial costs, it faces challenges in translating revenues into substantial profits.
Balance Sheet Strength and Financial Ratios
Gujarat Narmada Valley Fertilizers & Chemicals demonstrates a robust balance sheet, characterized by minimal borrowings of ₹106 Cr against total reserves of ₹8,305 Cr. This translates to a Debt to Equity ratio of 0.01, indicating a very low leverage and strong financial stability. The current ratio stands at 4.67, far surpassing the typical sector standard, suggesting ample liquidity to cover short-term liabilities. Additionally, the company has maintained a healthy Book Value per Share of ₹583.62, underpinning its asset base. However, the declining trend in operating profit from ₹1,879 Cr in March 2023 to ₹502 Cr in March 2024 raises concerns about its operational efficiency. The Price to Book Value (P/BV) ratio of 0.85x indicates that the stock is undervalued compared to its actual net asset value, presenting a potential investment opportunity if operational issues are addressed. Overall, while the balance sheet appears strong, the operational performance needs vigilant monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gujarat Narmada Valley Fertilizers & Chemicals illustrates a stable yet concentrated ownership structure. Promoters hold a significant 41.30% stake, which has remained consistent over recent quarters. Foreign Institutional Investors (FIIs) have reduced their stake from 20.47% in December 2022 to 12.08% by March 2025, indicating a potential decline in investor confidence. Domestic Institutional Investors (DIIs) have also seen a slight increase to 10.69%, reflecting a mixed sentiment among institutional players. The public holding has risen to 35.92%, suggesting increased retail interest. The total number of shareholders has also shown growth, reaching 2,75,857 by March 2025. This stability among promoters combined with fluctuating institutional investment levels points to a cautious market outlook, where retail investors may be capitalizing on perceived undervaluation while institutional investors reassess their positions.
Outlook, Risks, and Final Insight
Looking ahead, Gujarat Narmada Valley Fertilizers & Chemicals faces both opportunities and risks. The company’s strong balance sheet and low debt levels provide a buffer against market volatility, while the potential for recovery in sales presents growth opportunities. However, declining profitability and operational inefficiencies pose significant risks that could hinder future performance. Additionally, fluctuations in agricultural demand and global commodity prices can impact revenue stability. The company must focus on enhancing operational efficiency and cost management to improve profit margins and shareholder returns. Conditional scenarios suggest that if operational challenges are addressed effectively, the company could leverage its financial strength to capture market share and enhance profitability. Conversely, continued operational struggles may lead to further declines in investor confidence, particularly among institutional investors, which could affect stock performance negatively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Gujarat Narmada Valley Fertilizers & Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat State Fertilizers & Chemicals Ltd | 7,392 Cr. | 186 | 231/156 | 11.5 | 305 | 2.69 % | 6.18 % | 4.77 % | 2.00 |
| Bharat Agri Fert & Realty Ltd | 169 Cr. | 31.9 | 85.0/30.0 | 9.97 | 0.00 % | 6.14 % | 14.8 % | 1.00 | |
| Basant Agro Tech (India) Ltd | 123 Cr. | 13.5 | 21.5/11.0 | 27.9 | 19.6 | 0.37 % | 6.52 % | 2.36 % | 1.00 |
| Zuari Agro Chemicals Ltd | 1,108 Cr. | 264 | 395/155 | 3.20 | 602 | 0.00 % | 12.7 % | 9.06 % | 10.0 |
| Southern Petrochemicals Industries Corporation Ltd (SPIC) | 1,784 Cr. | 87.7 | 128/66.2 | 11.2 | 58.9 | 2.28 % | 16.9 % | 13.8 % | 10.0 |
| Industry Average | 10,753.05 Cr | 403.33 | 51.19 | 183.36 | 0.92% | 13.03% | 10.58% | 7.35 |
All Competitor Stocks of Gujarat Narmada Valley Fertilizers & Chemicals Ltd
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,696 | 2,587 | 2,673 | 2,271 | 1,652 | 2,080 | 2,088 | 2,110 | 2,021 | 1,917 | 1,899 | 2,055 | 1,601 |
| Expenses | 1,933 | 2,278 | 2,235 | 1,902 | 1,547 | 1,911 | 2,004 | 1,965 | 1,868 | 1,827 | 1,767 | 1,815 | 1,570 |
| Operating Profit | 763 | 309 | 438 | 369 | 105 | 169 | 84 | 145 | 153 | 90 | 132 | 240 | 31 |
| OPM % | 28% | 12% | 16% | 16% | 6% | 8% | 4% | 7% | 8% | 5% | 7% | 12% | 2% |
| Other Income | 76 | 85 | 77 | 123 | 88 | 152 | 121 | 108 | 99 | 123 | 157 | 122 | 150 |
| Interest | 2 | 1 | 1 | 1 | 1 | 1 | 7 | 4 | 17 | 2 | 3 | 1 | 2 |
| Depreciation | 76 | 77 | 76 | 74 | 76 | 78 | 76 | 78 | 78 | 76 | 75 | 74 | 74 |
| Profit before tax | 761 | 316 | 438 | 417 | 116 | 242 | 122 | 171 | 157 | 135 | 211 | 287 | 105 |
| Tax % | 25% | 25% | 26% | 20% | 27% | 26% | 22% | 26% | 27% | 24% | 25% | 27% | 26% |
| Net Profit | 569 | 237 | 324 | 334 | 85 | 178 | 95 | 127 | 115 | 102 | 158 | 210 | 78 |
| EPS in Rs | 36.61 | 15.25 | 20.85 | 21.49 | 5.47 | 11.45 | 6.47 | 8.64 | 7.83 | 6.94 | 10.75 | 14.29 | 5.31 |
Last Updated: August 20, 2025, 9:55 am
Below is a detailed analysis of the quarterly data for Gujarat Narmada Valley Fertilizers & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,601.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,055.00 Cr. (Mar 2025) to 1,601.00 Cr., marking a decrease of 454.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,570.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,815.00 Cr. (Mar 2025) to 1,570.00 Cr., marking a decrease of 245.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 240.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 209.00 Cr..
- For OPM %, as of Jun 2025, the value is 2.00%. The value appears to be declining and may need further review. It has decreased from 12.00% (Mar 2025) to 2.00%, marking a decrease of 10.00%.
- For Other Income, as of Jun 2025, the value is 150.00 Cr.. The value appears strong and on an upward trend. It has increased from 122.00 Cr. (Mar 2025) to 150.00 Cr., marking an increase of 28.00 Cr..
- For Interest, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 74.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 74.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 105.00 Cr.. The value appears to be declining and may need further review. It has decreased from 287.00 Cr. (Mar 2025) to 105.00 Cr., marking a decrease of 182.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 27.00% (Mar 2025) to 26.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 78.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 78.00 Cr., marking a decrease of 132.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 5.31. The value appears to be declining and may need further review. It has decreased from 14.29 (Mar 2025) to 5.31, marking a decrease of 8.98.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,847 | 4,642 | 4,552 | 4,589 | 5,837 | 5,896 | 5,162 | 5,129 | 8,642 | 10,227 | 7,930 | 7,892 | 7,472 |
| Expenses | 4,231 | 4,662 | 3,989 | 3,936 | 4,445 | 5,022 | 4,621 | 4,125 | 6,259 | 8,348 | 7,428 | 7,277 | 6,979 |
| Operating Profit | 616 | -21 | 563 | 653 | 1,392 | 874 | 542 | 1,003 | 2,384 | 1,879 | 502 | 615 | 493 |
| OPM % | 13% | -0% | 12% | 14% | 24% | 15% | 10% | 20% | 28% | 18% | 6% | 8% | 7% |
| Other Income | 45 | 52 | 252 | 517 | 140 | 215 | 153 | 237 | 209 | 361 | 469 | 501 | 552 |
| Interest | 92 | 274 | 297 | 203 | 100 | 6 | 5 | 20 | 3 | 5 | 13 | 23 | 8 |
| Depreciation | 145 | 209 | 251 | 251 | 270 | 263 | 264 | 272 | 292 | 303 | 308 | 303 | 299 |
| Profit before tax | 424 | -452 | 268 | 715 | 1,162 | 819 | 425 | 948 | 2,298 | 1,932 | 651 | 790 | 738 |
| Tax % | 31% | -0% | 35% | 27% | 32% | 10% | -17% | 27% | 26% | 24% | 26% | 26% | |
| Net Profit | 292 | -452 | 173 | 521 | 790 | 741 | 499 | 689 | 1,704 | 1,464 | 485 | 586 | 548 |
| EPS in Rs | 18.81 | -29.09 | 11.11 | 33.54 | 50.80 | 47.69 | 32.10 | 44.35 | 109.62 | 94.20 | 32.99 | 39.85 | 37.29 |
| Dividend Payout % | 19% | -0% | 18% | 15% | 15% | 15% | 16% | 18% | 9% | 32% | 50% | 45% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -254.79% | 138.27% | 201.16% | 51.63% | -6.20% | -32.66% | 38.08% | 147.31% | -14.08% | -66.87% | 20.82% |
| Change in YoY Net Profit Growth (%) | 0.00% | 393.07% | 62.88% | -149.52% | -57.83% | -26.46% | 70.73% | 109.24% | -161.40% | -52.79% | 87.70% |
Gujarat Narmada Valley Fertilizers & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | -3% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 3% |
| 3 Years: | -30% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 20% |
| 3 Years: | -11% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 10% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 5:35 am
Balance Sheet
Last Updated: October 10, 2025, 2:08 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 147 | 147 |
| Reserves | 2,790 | 2,325 | 3,122 | 3,646 | 4,303 | 4,842 | 5,067 | 5,828 | 7,743 | 8,851 | 8,051 | 8,305 |
| Borrowings | 3,904 | 3,844 | 3,101 | 1,959 | 303 | 208 | 860 | 4 | 2 | 2 | 3 | 106 |
| Other Liabilities | 2,420 | 2,164 | 2,130 | 2,142 | 2,411 | 2,337 | 2,261 | 2,321 | 2,764 | 2,613 | 2,405 | 2,366 |
| Total Liabilities | 9,270 | 8,488 | 8,509 | 7,903 | 7,172 | 7,542 | 8,344 | 8,309 | 10,664 | 11,621 | 10,606 | 10,924 |
| Fixed Assets | 4,873 | 4,468 | 4,367 | 4,442 | 4,161 | 3,959 | 3,810 | 3,720 | 3,578 | 3,381 | 3,238 | 3,094 |
| CWIP | 23 | 13 | 9 | 14 | 14 | 25 | 82 | 161 | 138 | 187 | 289 | 382 |
| Investments | 132 | 145 | 729 | 762 | 726 | 732 | 596 | 853 | 1,222 | 3,106 | 2,919 | 2,181 |
| Other Assets | 4,241 | 3,861 | 3,404 | 2,683 | 2,271 | 2,826 | 3,856 | 3,575 | 5,727 | 4,946 | 4,160 | 5,268 |
| Total Assets | 9,270 | 8,488 | 8,509 | 7,903 | 7,172 | 7,542 | 8,344 | 8,309 | 10,664 | 11,621 | 10,606 | 10,924 |
Below is a detailed analysis of the balance sheet data for Gujarat Narmada Valley Fertilizers & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 147.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 147.00 Cr..
- For Reserves, as of Mar 2025, the value is 8,305.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,051.00 Cr. (Mar 2024) to 8,305.00 Cr., marking an increase of 254.00 Cr..
- For Borrowings, as of Mar 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 103.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 2,366.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,405.00 Cr. (Mar 2024) to 2,366.00 Cr., marking a decrease of 39.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 10,924.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,606.00 Cr. (Mar 2024) to 10,924.00 Cr., marking an increase of 318.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 3,094.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,238.00 Cr. (Mar 2024) to 3,094.00 Cr., marking a decrease of 144.00 Cr..
- For CWIP, as of Mar 2025, the value is 382.00 Cr.. The value appears strong and on an upward trend. It has increased from 289.00 Cr. (Mar 2024) to 382.00 Cr., marking an increase of 93.00 Cr..
- For Investments, as of Mar 2025, the value is 2,181.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,919.00 Cr. (Mar 2024) to 2,181.00 Cr., marking a decrease of 738.00 Cr..
- For Other Assets, as of Mar 2025, the value is 5,268.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,160.00 Cr. (Mar 2024) to 5,268.00 Cr., marking an increase of 1,108.00 Cr..
- For Total Assets, as of Mar 2025, the value is 10,924.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,606.00 Cr. (Mar 2024) to 10,924.00 Cr., marking an increase of 318.00 Cr..
Notably, the Reserves (8,305.00 Cr.) exceed the Borrowings (106.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 613.00 | -24.00 | 560.00 | 652.00 | -302.00 | 666.00 | -318.00 | -3.00 | 0.00 | -1.00 | 499.00 | 509.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 107 | 119 | 88 | 70 | 77 | 100 | 36 | 26 | 13 | 29 | 20 |
| Inventory Days | 99 | 98 | 107 | 110 | 98 | 106 | 125 | 129 | 91 | 84 | 94 | 105 |
| Days Payable | 35 | 39 | 40 | 57 | 61 | 50 | 68 | 63 | 59 | 42 | 42 | 40 |
| Cash Conversion Cycle | 173 | 166 | 186 | 142 | 107 | 132 | 156 | 103 | 58 | 55 | 81 | 84 |
| Working Capital Days | -7 | 9 | 8 | 27 | 57 | 76 | 117 | 68 | 97 | 46 | 58 | 61 |
| ROCE % | 8% | -3% | 9% | 10% | 24% | 17% | 8% | 16% | 33% | 23% | 8% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Smallcap Fund | 1,895,613 | 1.48 | 129.57 | 1,895,613 | 2025-04-22 17:25:33 | 0% |
| ICICI Prudential Multi Asset Fund | 1,371,661 | 0.19 | 93.75 | 1,371,661 | 2025-04-22 17:25:33 | 0% |
| ICICI Prudential Multicap Fund | 1,092,557 | 0.52 | 74.68 | 1,092,557 | 2025-04-22 17:25:33 | 0% |
| HSBC Value Fund | 689,200 | 0.34 | 47.11 | 689,200 | 2025-04-22 15:56:57 | 0% |
| Kotak Equity Arbitrage Fund - Regular Plan | 681,200 | 0.09 | 46.56 | 681,200 | 2025-04-22 17:25:33 | 0% |
| ICICI Prudential Manufacturing Fund | 622,745 | 0.63 | 42.56 | 622,745 | 2025-04-22 17:25:34 | 0% |
| SBI Arbitrage Opportunities Fund | 520,000 | 0.11 | 35.54 | 520,000 | 2025-04-22 17:25:34 | 0% |
| Invesco India Arbitrage Fund | 432,900 | 0.17 | 29.59 | 432,900 | 2025-04-22 17:25:34 | 0% |
| Aditya Birla Sun Life Arbitrage Fund | 405,600 | 0.21 | 27.72 | 405,600 | 2025-04-22 15:56:57 | 0% |
| HSBC Arbitrage Fund | 387,400 | 1.06 | 26.48 | 387,400 | 2025-04-22 15:56:57 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 40.68 | 32.47 | 94.68 | 110.05 | 44.84 |
| Diluted EPS (Rs.) | 40.68 | 32.47 | 94.68 | 110.05 | 44.84 |
| Cash EPS (Rs.) | 60.46 | 53.92 | 113.69 | 128.39 | 61.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 583.62 | 565.45 | 585.84 | 514.09 | 390.44 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 583.62 | 565.45 | 585.84 | 514.09 | 390.44 |
| Revenue From Operations / Share (Rs.) | 537.12 | 539.66 | 658.02 | 556.06 | 329.99 |
| PBDIT / Share (Rs.) | 75.96 | 66.09 | 144.11 | 166.85 | 79.82 |
| PBIT / Share (Rs.) | 55.35 | 45.16 | 124.62 | 148.08 | 62.30 |
| PBT / Share (Rs.) | 53.79 | 44.31 | 124.28 | 147.86 | 61.02 |
| Net Profit / Share (Rs.) | 39.85 | 32.99 | 94.19 | 109.62 | 44.34 |
| NP After MI And SOA / Share (Rs.) | 40.68 | 33.83 | 94.68 | 110.05 | 44.84 |
| PBDIT Margin (%) | 14.14 | 12.24 | 21.90 | 30.00 | 24.18 |
| PBIT Margin (%) | 10.30 | 8.36 | 18.93 | 26.63 | 18.87 |
| PBT Margin (%) | 10.01 | 8.21 | 18.88 | 26.59 | 18.49 |
| Net Profit Margin (%) | 7.41 | 6.11 | 14.31 | 19.71 | 13.43 |
| NP After MI And SOA Margin (%) | 7.57 | 6.26 | 14.38 | 19.79 | 13.58 |
| Return on Networth / Equity (%) | 6.97 | 5.98 | 16.16 | 21.40 | 11.48 |
| Return on Capital Employeed (%) | 8.25 | 6.91 | 18.61 | 24.57 | 13.04 |
| Return On Assets (%) | 5.43 | 4.65 | 12.58 | 15.95 | 8.31 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.72 | 0.70 | 0.91 | 0.90 | 0.61 |
| Current Ratio (X) | 4.67 | 4.14 | 3.77 | 3.61 | 3.57 |
| Quick Ratio (X) | 3.57 | 3.11 | 2.90 | 2.89 | 2.73 |
| Inventory Turnover Ratio (X) | 6.64 | 5.25 | 6.66 | 5.60 | 3.43 |
| Dividend Payout Ratio (NP) (%) | 40.55 | 93.80 | 10.56 | 7.26 | 11.15 |
| Dividend Payout Ratio (CP) (%) | 26.92 | 57.94 | 8.75 | 6.21 | 8.01 |
| Earning Retention Ratio (%) | 59.45 | 6.20 | 89.44 | 92.74 | 88.85 |
| Cash Earning Retention Ratio (%) | 73.08 | 42.06 | 91.25 | 93.79 | 91.99 |
| Interest Coverage Ratio (X) | 48.63 | 77.57 | 425.81 | 749.48 | 62.18 |
| Interest Coverage Ratio (Post Tax) (X) | 26.51 | 39.72 | 279.32 | 493.41 | 35.55 |
| Enterprise Value (Cr.) | 5084.86 | 7652.47 | 5923.19 | 11944.13 | 3224.13 |
| EV / Net Operating Revenue (X) | 0.64 | 0.96 | 0.57 | 1.38 | 0.62 |
| EV / EBITDA (X) | 4.56 | 7.88 | 2.64 | 4.61 | 2.60 |
| MarketCap / Net Operating Revenue (X) | 0.92 | 1.16 | 0.77 | 1.52 | 0.91 |
| Retention Ratios (%) | 59.44 | 6.19 | 89.43 | 92.73 | 88.84 |
| Price / BV (X) | 0.85 | 1.10 | 0.86 | 1.64 | 0.77 |
| Price / Net Operating Revenue (X) | 0.92 | 1.16 | 0.77 | 1.52 | 0.91 |
| EarningsYield | 0.08 | 0.05 | 0.18 | 0.13 | 0.14 |
After reviewing the key financial ratios for Gujarat Narmada Valley Fertilizers & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 40.68. This value is within the healthy range. It has increased from 32.47 (Mar 24) to 40.68, marking an increase of 8.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 40.68. This value is within the healthy range. It has increased from 32.47 (Mar 24) to 40.68, marking an increase of 8.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 60.46. This value is within the healthy range. It has increased from 53.92 (Mar 24) to 60.46, marking an increase of 6.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 583.62. It has increased from 565.45 (Mar 24) to 583.62, marking an increase of 18.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 583.62. It has increased from 565.45 (Mar 24) to 583.62, marking an increase of 18.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 537.12. It has decreased from 539.66 (Mar 24) to 537.12, marking a decrease of 2.54.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 75.96. This value is within the healthy range. It has increased from 66.09 (Mar 24) to 75.96, marking an increase of 9.87.
- For PBIT / Share (Rs.), as of Mar 25, the value is 55.35. This value is within the healthy range. It has increased from 45.16 (Mar 24) to 55.35, marking an increase of 10.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 53.79. This value is within the healthy range. It has increased from 44.31 (Mar 24) to 53.79, marking an increase of 9.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 39.85. This value is within the healthy range. It has increased from 32.99 (Mar 24) to 39.85, marking an increase of 6.86.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 40.68. This value is within the healthy range. It has increased from 33.83 (Mar 24) to 40.68, marking an increase of 6.85.
- For PBDIT Margin (%), as of Mar 25, the value is 14.14. This value is within the healthy range. It has increased from 12.24 (Mar 24) to 14.14, marking an increase of 1.90.
- For PBIT Margin (%), as of Mar 25, the value is 10.30. This value is within the healthy range. It has increased from 8.36 (Mar 24) to 10.30, marking an increase of 1.94.
- For PBT Margin (%), as of Mar 25, the value is 10.01. This value is within the healthy range. It has increased from 8.21 (Mar 24) to 10.01, marking an increase of 1.80.
- For Net Profit Margin (%), as of Mar 25, the value is 7.41. This value is within the healthy range. It has increased from 6.11 (Mar 24) to 7.41, marking an increase of 1.30.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.57. This value is below the healthy minimum of 8. It has increased from 6.26 (Mar 24) to 7.57, marking an increase of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.97. This value is below the healthy minimum of 15. It has increased from 5.98 (Mar 24) to 6.97, marking an increase of 0.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.25. This value is below the healthy minimum of 10. It has increased from 6.91 (Mar 24) to 8.25, marking an increase of 1.34.
- For Return On Assets (%), as of Mar 25, the value is 5.43. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 5.43, marking an increase of 0.78.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.72. It has increased from 0.70 (Mar 24) to 0.72, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 4.67. This value exceeds the healthy maximum of 3. It has increased from 4.14 (Mar 24) to 4.67, marking an increase of 0.53.
- For Quick Ratio (X), as of Mar 25, the value is 3.57. This value exceeds the healthy maximum of 2. It has increased from 3.11 (Mar 24) to 3.57, marking an increase of 0.46.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.64. This value is within the healthy range. It has increased from 5.25 (Mar 24) to 6.64, marking an increase of 1.39.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 40.55. This value is within the healthy range. It has decreased from 93.80 (Mar 24) to 40.55, marking a decrease of 53.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 26.92. This value is within the healthy range. It has decreased from 57.94 (Mar 24) to 26.92, marking a decrease of 31.02.
- For Earning Retention Ratio (%), as of Mar 25, the value is 59.45. This value is within the healthy range. It has increased from 6.20 (Mar 24) to 59.45, marking an increase of 53.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 73.08. This value exceeds the healthy maximum of 70. It has increased from 42.06 (Mar 24) to 73.08, marking an increase of 31.02.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 48.63. This value is within the healthy range. It has decreased from 77.57 (Mar 24) to 48.63, marking a decrease of 28.94.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 26.51. This value is within the healthy range. It has decreased from 39.72 (Mar 24) to 26.51, marking a decrease of 13.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 5,084.86. It has decreased from 7,652.47 (Mar 24) to 5,084.86, marking a decrease of 2,567.61.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.64, marking a decrease of 0.32.
- For EV / EBITDA (X), as of Mar 25, the value is 4.56. This value is below the healthy minimum of 5. It has decreased from 7.88 (Mar 24) to 4.56, marking a decrease of 3.32.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.92, marking a decrease of 0.24.
- For Retention Ratios (%), as of Mar 25, the value is 59.44. This value is within the healthy range. It has increased from 6.19 (Mar 24) to 59.44, marking an increase of 53.25.
- For Price / BV (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has decreased from 1.10 (Mar 24) to 0.85, marking a decrease of 0.25.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 24) to 0.92, marking a decrease of 0.24.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Narmada Valley Fertilizers & Chemicals Ltd:
- Net Profit Margin: 7.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.25% (Industry Average ROCE: 13.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.97% (Industry Average ROE: 10.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 26.51
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.57
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.2 (Industry average Stock P/E: 51.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.41%
FAQ
What is the intrinsic value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
Gujarat Narmada Valley Fertilizers & Chemicals Ltd's intrinsic value (as of 10 November 2025) is 442.48 which is 10.07% lower the current market price of 492.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,245 Cr. market cap, FY2025-2026 high/low of 664/449, reserves of ₹8,305 Cr, and liabilities of 10,924 Cr.
What is the Market Cap of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Market Cap of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 7,245 Cr..
What is the current Stock Price of Gujarat Narmada Valley Fertilizers & Chemicals Ltd as on 10 November 2025?
The current stock price of Gujarat Narmada Valley Fertilizers & Chemicals Ltd as on 10 November 2025 is 492.
What is the High / Low of Gujarat Narmada Valley Fertilizers & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Narmada Valley Fertilizers & Chemicals Ltd stocks is 664/449.
What is the Stock P/E of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Stock P/E of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 13.2.
What is the Book Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Book Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 575.
What is the Dividend Yield of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Dividend Yield of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 3.66 %.
What is the ROCE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The ROCE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 9.70 %.
What is the ROE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The ROE of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 7.03 %.
What is the Face Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd?
The Face Value of Gujarat Narmada Valley Fertilizers & Chemicals Ltd is 10.0.